Cowen Investment Management’s LAVA Medtech Acquisition Corp. Unit LVACU Stock Holding History

Cowen Investment Management’s Portfolio LVACU Stock Details LVACU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-100,000	Closed	-$1.02M	–	250
2022 Q4	$1.02M	Hold	100,000	–	–	0.21%	103
2022 Q3	$1M	Hold	100,000	–	–	0.22%	115
2022 Q2	$1M	Hold	100,000	–	–	0.21%	105
2022 Q1	$1.01M	Hold	100,000	–	–	0.22%	95
2021 Q4	$1.01M	Buy	+100,000	New	+$1.01M	0.22%	90

Other funds holding LVACU

SIA

Schechter Investment Advisors Birmingham, Michigan $1.21B AUM 8.72% 1-Year Est. Return

Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

Clear Street New York $24.6B AUM 56.25% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

Cowen Investment Management's LVACU Position: Q1 2023 in Review

Cowen Investment Management sold out of LAVA Medtech Acquisition Corp. Unit (LVACU) in Q1 2023, closing a stake of 100,000 shares — an estimated $1.02M sold.

Cowen Investment Management first reported a position in LVACU in Q4 2021 and held it in 5 quarters. The position peaked at $1.02M in Q4 2022. 4 funds tracked by Wall St. Rank hold LVACU as of Q1 2023.

Cowen Investment Management reported no remaining LAVA Medtech Acquisition Corp. Unit position as of Q1 2023 after selling out during the quarter.
Cowen Investment Management sold 100,000 LAVA Medtech Acquisition Corp. Unit shares in Q1 2023, an estimated $1.02M.
Cowen Investment Management first reported a position in LAVA Medtech Acquisition Corp. Unit in Q4 2021 and held it in 5 quarters.
Cowen Investment Management's LAVA Medtech Acquisition Corp. Unit position peaked at $1.02M in Q4 2022.
4 funds tracked by Wall St. Rank held LAVA Medtech Acquisition Corp. Unit as of Q1 2023.

Based on Cowen Investment Management's 13F filing for Q1 2023, filed 11 May 2023.